SHARE-BASED COMPENSATION (Tables)
|
12 Months Ended |
Dec. 31, 2021 |
|---|
| Equity [Abstract] |
|
| Schedule of common stock reserved for future issuance under employee stock plans |
| Schedule of common stock reserved for future issuance under employee stock plans |
|
|
|
|
| Plans |
|
Number of Shares |
|
| Total awards available to be issued |
|
|
3,059,623 |
|
| Total awards outstanding |
|
|
8,452,376 |
|
| Total Common Stock reserved for future issuance under employee stock plans |
|
|
11,511,999 |
|
|
| Schedule of summarizes share-based compensation expense |
| Schedule of summarizes share-based compensation expense |
|
|
|
|
|
|
|
|
| |
|
December 31, |
|
| |
|
2021 |
|
|
2020 |
|
| Research and development |
|
$ |
1,812 |
|
|
$ |
854 |
|
| Sales and marketing |
|
|
1,925 |
|
|
|
561 |
|
| General and administrative |
|
|
6,759 |
|
|
|
1,172 |
|
| Cost of sales |
|
|
81 |
|
|
|
56 |
|
| Total share-based compensation |
|
$ |
10,577 |
|
|
$ |
2,643 |
|
|
| Schedule of fair value of the stock options assumptions |
| Schedule
of fair value of the stock options assumptions |
|
|
|
|
|
|
|
|
| |
|
Year Ended
December 31, |
|
| |
|
2021 |
|
|
2020 |
|
| Weighted-average grant date price of our common stock (per share) |
|
$ |
3.99 |
|
|
$ |
12.78 |
|
| Risk-free interest rate |
|
|
1.19 |
% |
|
|
0.55 |
% |
| Expected volatility |
|
|
33.0 |
% |
|
|
68.0 |
% |
| Expected term (in years) |
|
|
5 |
|
|
|
5 |
|
| Expected dividend yield |
|
|
— |
% |
|
|
— |
% |
|
| Schedule of common stock options |
| Schedule of common stock options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
Number of Shares |
|
|
Weighted Average Exercise Price |
|
|
Weighted Average Remaining Contractual Life (Years) |
|
|
Weighted-Average Grant Date Fair Value |
|
| Outstanding, December 31, 2020 |
|
|
|
5,500,135 |
|
|
$ |
3.99 |
|
|
|
6.79 |
|
|
$ |
2.37 |
|
| Granted |
|
|
|
498,164 |
|
|
|
6.36 |
|
|
|
|
|
|
|
3.99 |
|
| Exercised |
|
|
|
(327,954 |
) |
|
|
3.28 |
|
|
|
|
|
|
|
1.62 |
|
| Forfeited |
|
|
|
(96,167 |
) |
|
|
5.39 |
|
|
|
|
|
|
|
2.88 |
|
| Expired |
|
|
|
(84,686 |
) |
|
|
3.31 |
|
|
|
|
|
|
|
1.72 |
|
| Outstanding, December 31, 2021(a) |
|
|
|
5,489,492 |
|
|
$ |
4.23 |
|
|
|
6.05 |
|
|
$ |
2.27 |
|
| Exercisable, December 31, 2021(b) |
|
|
|
3,939,056 |
|
|
$ |
3.85 |
|
|
|
5.24 |
|
|
$ |
1.98 |
|
| (a) |
The aggregate intrinsic value of all stock options outstanding as of December 31, 2021 was $2.2 million. |
| (b) |
The aggregate intrinsic value of all vested/exercisable stock options as of December 31, 2021 was $2.2 million. |
|
| Schedule of restricted stock awards |
| Schedule of restricted stock awards |
|
|
|
|
|
|
|
|
|
| |
|
|
Number of
Shares |
|
|
Weighted Average
Grant Date
Fair Value |
|
| Outstanding
(nonvested), December 31, 2020 |
|
|
|
337,187 |
|
|
$ |
3.83 |
|
| Granted |
|
|
|
371,037 |
|
|
|
9.51 |
|
| Forfeited |
|
|
|
(356,393 |
) |
|
|
4.04 |
|
| Outstanding
(nonvested), December 31, 2021 |
|
|
|
351,831 |
|
|
$ |
9.63 |
|
|
| Schedule of restricted stock units |
| Schedule of restricted stock units |
|
|
|
|
|
|
|
|
|
| |
|
|
Number of
RSUs |
|
|
Weighted Average
Grant Date
Fair Value |
|
| Outstanding
(nonvested), December 31, 2020 |
|
|
|
— |
|
|
$ |
— |
|
| Granted |
|
|
|
2,964,884 |
|
|
|
8.60 |
|
| Forfeited |
|
|
|
(2,000 |
) |
|
|
6.94 |
|
| Outstanding
(nonvested), December 31, 2021 |
|
|
|
2,962,884 |
|
|
$ |
8.60 |
|
|